Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant Staphylococcus aureus: In Silico and In Vitro Approach.

Front Cell Infect Microbiol · 2021 · PMC8415528 · PMID 34485178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

The data were quite significant to show that the clinical isolate Sa -P2003 was observed to overexpress norA , as the cycle threshold (CT) value was several folds lesser in comparison with the other strains ( Figure S2 ).

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant <i>Staphylococcus aureus</i>: <i>In Silico</i> and <i>In Vitro</i> Approach.

The sentences